Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kallyope
Special Reports
Biotech's top money raisers: 2022
After two record-setting years, private biotech fundraises finally fell, dipping 24% from the highs of 2021.
Gabrielle Masson
Apr 11, 2023 9:19am
Catalent shakes up leadership, taps new CEO—Chutes & Ladders
Jul 8, 2022 9:30am
New report surveys declining biopharma deal activity in Q1
Jun 9, 2022 4:56am
Kallyope delays IPO to snag $236M series D for 22 programs
Feb 15, 2022 8:00am
Former Merck exec joins Kallyope as president, soon-to-be CEO
Aug 5, 2021 11:56am
Kallyope aims for the clinic with $112M raise
Mar 25, 2020 6:00am
